1
Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, J.E.M., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van 't Hof, A. W. J., Hermanides, R. S.
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021
2
Al-Farra, Hatem, Abu-Hanna, Ameen, de Mol, Bas A.J.M., ter Burg, W.J., Houterman, Saskia, Henriques, José P.S., Ravelli, Anita C.J., Vis, M.M., Vos, J., Ten Berg, J., Tonino, W.A.L., Schotborgh, C.E., Roolvink, V., Porta, F., Stoel, M., Kats, S., Amoroso, G., van der Werf, H.W., Stella, P.R., de Jaegere, P.
Veröffentlicht in: International Journal of Cardiology ; volume 317, page 25-32 ; ISSN 0167-5273;
2020
Veröffentlicht in: International Journal of Cardiology ; volume 317, page 25-32 ; ISSN 0167-5273;
2020